Literature DB >> 20689511

Primer-free aptamer selection using a random DNA library.

Weihua Pan1, Ping Xin, Susan Patrick, Stacey Dean, Christine Keating, Gary Clawson.   

Abstract

Aptamers are highly structured oligonucleotides (DNA or RNA) that can bind to targets with affinities comparable to antibodies (1). They are identified through an in vitro selection process called Systematic Evolution of Ligands by EXponential enrichment (SELEX) to recognize a wide variety of targets, from small molecules to proteins and other macromolecules (2-4). Aptamers have properties that are well suited for in vivo diagnostic and/or therapeutic applications: Besides good specificity and affinity, they are easily synthesized, survive more rigorous processing conditions, they are poorly immunogenic, and their relatively small size can result in facile penetration of tissues. Aptamers that are identified through the standard SELEX process usually comprise approximately 80 nucleotides (nt), since they are typically selected from nucleic acid libraries with approximately 40 nt long randomized regions plus fixed primer sites of approximately 20 nt on each side. The fixed primer sequences thus can comprise nearly approximately 50% of the library sequences, and therefore may positively or negatively compromise identification of aptamers in the selection process (3), although bioinformatics approaches suggest that the fixed sequences do not contribute significantly to aptamer structure after selection (5). To address these potential problems, primer sequences have been blocked by complementary oligonucleotides or switched to different sequences midway during the rounds of SELEX (6), or they have been trimmed to 6-9 nt (7, 8). Wen and Gray (9) designed a primer-free genomic SELEX method, in which the primer sequences were completely removed from the library before selection and were then regenerated to allow amplification of the selected genomic fragments. However, to employ the technique, a unique genomic library has to be constructed, which possesses limited diversity, and regeneration after rounds of selection relies on a linear reamplification step. Alternatively, efforts to circumvent problems caused by fixed primer sequences using high efficiency partitioning are met with problems regarding PCR amplification (10). We have developed a primer-free (PF) selection method that significantly simplifies SELEX procedures and effectively eliminates primer-interference problems (11, 12). The protocols work in a straightforward manner. The central random region of the library is purified without extraneous flanking sequences and is bound to a suitable target (for example to a purified protein or complex mixtures such as cell lines). Then the bound sequences are obtained, reunited with flanking sequences, and re-amplified to generate selected sub-libraries. As an example, here we selected aptamers to S100B, a protein marker for melanoma. Binding assays showed Kd s in the 10(-7) - 10(-8) M range after a few rounds of selection, and we demonstrate that the aptamers function effectively in a sandwich binding format.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689511      PMCID: PMC3156072          DOI: 10.3791/2039

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: genomic SELEX.

Authors:  T Shtatland; S C Gill; B E Javornik; H E Johansson; B S Singer; O C Uhlenbeck; D A Zichi; L Gold
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Submicrometer metallic barcodes.

Authors:  S R Nicewarner-Pena; R G Freeman; B D Reiss; L He; D J Pena; I D Walton; R Cromer; C D Keating; M J Natan
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

3.  Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX.

Authors:  Axel Vater; Florian Jarosch; Klaus Buchner; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

4.  Selection of genomic sequences that bind tightly to Ff gene 5 protein: primer-free genomic SELEX.

Authors:  Jin-Der Wen; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

Review 5.  Gene therapy progress and prospects: RNA aptamers.

Authors:  N S Que-Gewirth; B A Sullenger
Journal:  Gene Ther       Date:  2007-02       Impact factor: 5.250

Review 6.  Aptamers: molecular tools for analytical applications.

Authors:  Teresa Mairal; Veli Cengiz Ozalp; Pablo Lozano Sánchez; Mònica Mir; Ioanis Katakis; Ciara K O'Sullivan
Journal:  Anal Bioanal Chem       Date:  2007-06-21       Impact factor: 4.142

Review 7.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Authors:  Regina Stoltenburg; Christine Reinemann; Beate Strehlitz
Journal:  Biomol Eng       Date:  2007-06-16

8.  Selection of aptamers by systematic evolution of ligands by exponential enrichment: addressing the polymerase chain reaction issue.

Authors:  Michael U Musheev; Sergey N Krylov
Journal:  Anal Chim Acta       Date:  2005-11-02       Impact factor: 6.558

9.  Minimal primer and primer-free SELEX protocols for selection of aptamers from random DNA libraries.

Authors:  Weihua Pan; Ping Xin; Gary A Clawson
Journal:  Biotechniques       Date:  2008-03       Impact factor: 1.993

10.  In vitro selection using a dual RNA library that allows primerless selection.

Authors:  Florian Jarosch; Klaus Buchner; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

View more
  7 in total

1.  Strategies for the discovery of therapeutic aptamers.

Authors:  Xianbin Yang; Na Li; David G Gorenstein
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

2.  Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells.

Authors:  Lindsay Jones Talbot; Zhiyong Mi; Syamal Dave Bhattacharya; Victoria Kim; Hongtao Guo; Paul C Kuo
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

3.  S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.

Authors:  Andreia Barateiro; Vera Afonso; Gisela Santos; João José Cerqueira; Dora Brites; Jack van Horssen; Adelaide Fernandes
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

4.  Selection of aptamers for AMACR detection from DNA libraries with different primers.

Authors:  Deng-Kai Yang; Chia-Fu Chou; Lin-Chi Chen
Journal:  RSC Adv       Date:  2018-05-23       Impact factor: 4.036

Review 5.  Aptamer Selection Technology and Recent Advances.

Authors:  Michael Blind; Michael Blank
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-06       Impact factor: 8.886

Review 6.  Key Aspects of Nucleic Acid Library Design for in Vitro Selection.

Authors:  Maria A Vorobyeva; Anna S Davydova; Pavel E Vorobjev; Alya G Venyaminova
Journal:  Int J Mol Sci       Date:  2018-02-05       Impact factor: 5.923

7.  Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.

Authors:  Marlies Gijs; Gregory Penner; Garth B Blackler; Nathalie R E N Impens; Sarah Baatout; André Luxen; An M Aerts
Journal:  Pharmaceuticals (Basel)       Date:  2016-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.